0001127602-11-011160.txt : 20110324
0001127602-11-011160.hdr.sgml : 20110324
20110324173839
ACCESSION NUMBER: 0001127602-11-011160
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110322
FILED AS OF DATE: 20110324
DATE AS OF CHANGE: 20110324
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Haluska Frank
CENTRAL INDEX KEY: 0001494892
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21696
FILM NUMBER: 11710341
MAIL ADDRESS:
STREET 1: C/O ARIAD PHARMACEUTICALS, INC.
STREET 2: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000884731
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 223106987
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 LANDSDOWNE ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6174940400
MAIL ADDRESS:
STREET 1: 26 LANDSDOWNE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
form4.xml
PRIMARY DOCUMENT
X0303
4
2011-03-22
0000884731
ARIAD PHARMACEUTICALS INC
ARIA
0001494892
Haluska Frank
C/O ARIAD PHARMACEUTICALS, INC.
26 LANDSDOWNE STREET
CAMBRIDGE
MA
02139
1
VP, Clinical R&D, CMO
Common Stock
2011-03-22
4
M
0
13334
0
A
28265
D
Common Stock
2011-03-22
4
F
0
4400
6.39
D
23865
D
Restricted Stock Units
0
2011-03-22
4
M
0
13334
0
D
2020-03-22
Common Stock
13334
26666
D
The restricted stock units will vest 33.33% on March 22, 2011, 2012, and 2013. 13,334 shares will be delivered to the reporting person on or about March 22, 2011 and 13,333 shares will be delivered to the reporting person on or about each of March 22, 2012 and 2013.
Represents shares withheld to satisfy withholding tax requirements.
Shares were acquired upon vesting of restricted stock units awarded on 03/22/2010.
/s/Edward M. Fitzgerald, Attorney-in-Fact
2011-03-24